0001549595-12-000001.txt : 20120515 0001549595-12-000001.hdr.sgml : 20120515 20120515170407 ACCESSION NUMBER: 0001549595-12-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20120515 DATE AS OF CHANGE: 20120515 EFFECTIVENESS DATE: 20120515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nurix, Inc. CENTRAL INDEX KEY: 0001549595 IRS NUMBER: 270838048 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-178327 FILM NUMBER: 12845787 BUSINESS ADDRESS: STREET 1: 1700 OWENS STREET, SUITE 500 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: (415) 865-2057 MAIL ADDRESS: STREET 1: 1700 OWENS STREET, SUITE 500 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 D 1 primary_doc.xml X0705 D LIVE 0001549595 Nurix, Inc. 1700 OWENS STREET, SUITE 500 SAN FRANCISCO CA CALIFORNIA 94158 (415) 865-2057 DELAWARE Kura Therapeutics, Inc. None Corporation true 2009 Timothy Kutzkey 1700 Owens St.., Suite 500 San Francisco CA CALIFORNIA 94158 Executive Officer Director David Goeddel 1700 Owens St.., Suite 500 San Francisco CA CALIFORNIA 94158 Director Other Decline to Disclose 06 false 2012-04-30 false true false 0 3100000 3100000 0 Porceeds are to be used for working capital. false 4 0 0 0 false Nurix, Inc. /s/Michael E. Tenta Michael E. Tenta Secretary 2012-05-15